Technical Analysis
Comprehensive insights into market trends, chart patterns, and key indicators. Equip yourself with the tools and strategies to make data-driven trading decisions.
US stocks closed lower, ending a strong 2024 but with tech giants retreating as investors secured profits. Focus now shifts to 2025, with the Fed’s rate policy and Trump’s return posing key market drivers.
US Stock Market Closes Lower, Ending a Year of Significant Gains Read More »
2024 saw a shift in corporate debt restructuring, with key players like David Nemecek and Scott Greenberg pioneering innovative strategies. Learn how these experts navigated high interest rates and distressed companies, impacting both private equity and debt investors.
Key Players Reshaping Debt Restructuring in 2024 Read More »
SPACs are unexpectedly surging again after a major crash, raising $8.7B since April despite past underperformance and regulatory scrutiny. Is this renewed interest a sign of market froth or a strategic bet on future IPO potential?
The Surprising Resurgence of SPACs: A Signal of Market Froth? Read More »
Bitcoin’s drop to $96,000 sparks debate: buying opportunity or trend reversal? Bitwise CIO calls it a healthy correction within a continuing bull market, citing strong institutional interest and positive fundamentals.
Bitcoin’s Dip: A Buying Opportunity or a Trend Reversal? Read More »
Bukalapak exits Indonesian physical goods sales due to fierce competition from giants like Shopee and TikTok Shop. The company will focus on virtual products, marking a major shift in its business model after struggling against international rivals.
Bukalapak Exits Physical Goods Sales Amidst Fierce E-Commerce Competition Read More »
Bitcoin price predictions for 2024 converge around $150K, fueled by a surge past $100K and strong institutional adoption. Experts cite technical indicators and growing mainstream acceptance as key drivers for continued growth.
Bitcoin Price Predictions for 2024: Experts Eye $150K Target Read More »
Novartis to close MorphoSys sites in Munich and Boston, impacting 330 jobs by end of 2025. This restructuring follows Novartis’ acquisition of MorphoSys and reflects a shift in R&D strategy.
Novartis to Close MorphoSys Sites, Impacting 330 Jobs Read More »
Two undervalued stocks, Quanterix (QTRX) and Green Plains (GPRE), are poised for a 2025 rebound despite significant price drops this year. Wall Street analysts predict strong growth potential for both, making them compelling investment opportunities.
Unearthing Undervalued Gems: Two Stocks Poised for a 2025 Rebound Read More »
November jobs report fuels market optimism for a Fed rate cut, pushing tech stocks higher. Strong job growth coupled with a slight rise in unemployment suggests a “Goldilocks” scenario, bolstering rate cut expectations.
November Jobs Report Fuels Market Optimism for Fed Rate Cut Read More »
J&J sues Cigna, alleging the insurer and its PBM shifted patient drug co-pays onto J&J’s assistance funds. This allegedly depleted resources meant for patients and unfairly benefited Cigna.
Johnson & Johnson Sues Cigna Over Patient Financial Assistance Program Read More »
